180 Life Sciences (ATNF) Short Interest Ratio & Short Volume

$1.52

+0.16 (+11.76%)

(As of 10/15/2024 ET)

180 Life Sciences Short Interest Data

180 Life Sciences (ATNF) has a short interest of 73,300 shares, representing 14.10% of the float (the number of shares available for trading by the public). This marks a 20.96% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.8, indicating that it would take 0.8 days of the average trading volume of 264,747 shares to cover all short positions.

Current Short Interest: 73,300 shares
Previous Short Interest: 60,600 shares
Change Vs. Previous Month: +20.96%
Dollar Volume Sold Short: $123,877.00
Short Interest Ratio: 0.8 Days to Cover
Last Record Date: September 30, 2024

Outstanding Shares: 942,000 shares
Float Size: 519,800 shares
Short Percent of Float: 14.10%
Today's Trading Volume: 65,701 shares
Average Trading Volume: 264,747 shares
Today's Volume Vs. Average: 25%

Short Selling 180 Life Sciences?

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for 180 Life Sciences and its competitors with MarketBeat's FREE newsletter.

Short Interest Chart Days to Cover Chart Short Percent of Float Chart

ATNF Short Interest Over Time

ATNF Days to Cover Over Time

ATNF Percentage of Float Shorted Over Time

Ad Paradigm Press

Musk’s new company could top a trillion?

The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840.

Click here to see the details because there’s not much time to prepare.

180 Life Sciences Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
9/30/2024	73,300 shares	$123,877.00	+21.0%	14.1%	0.8	$1.69
9/15/2024	60,600 shares	$109,686.00	+78.8%	11.7%	0.1	$1.81
8/31/2024	33,900 shares	$61,359.00	+5.3%	6.5%	0.1	$1.81
8/15/2024	32,200 shares	$60,536.00	-29.7%	6.2%	0.1	$1.88
7/31/2024	45,800 shares	$95,264.00	-67.5%	8.8%	0.1	$2.08
7/15/2024	140,800 shares	$285,824.00	+249.4%	27.2%	0.2	$2.03
Get the Latest News and Ratings for ATNF and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for 180 Life Sciences and its competitors with MarketBeat's FREE daily newsletter.
6/30/2024	40,300 shares	$66,495.00	+13.2%	7.8%	0.1	$1.65
6/15/2024	35,600 shares	$55,180.00	-19.8%	6.9%	0.3	$1.55
5/31/2024	44,400 shares	$71,928.00	+156.7%	8.6%	0.3	$1.62
5/15/2024	17,300 shares	$33,562.00	-36.9%	3.4%	0.1	$1.94
4/30/2024	27,400 shares	$58,910.00	+60.2%	5.3%	0.3	$2.15
4/15/2024	17,100 shares	$34,542.00	-59.7%	3.3%	0.2	$2.02
3/31/2024	42,400 shares	$98,792.00	-31.4%	8.4%	0.4	$2.33
3/15/2024	61,800 shares	$216,300.00	+309.3%	12.2%	0.6	$3.50
2/29/2024	15,100 shares	$53,152.00	-95.6%	3.0%	0.2	$3.52
2/15/2024	342,100 shares	$1.36 million	-22.8%	3.6%	0.3	$3.99
1/31/2024	443,300 shares	$94,866.20	-61.8%	4.6%	0.4	$0.21
1/15/2024	1,160,000 shares	$234,552.00	+195.7%	12.2%	1	$0.20
12/31/2023	392,300 shares	$83,756.05	-32.9%	4.1%	0.4	$0.21
12/15/2023	584,700 shares	$109,923.60	-4.0%	6.2%	1	$0.19
11/30/2023	608,900 shares	$165,011.90	+281.3%	8.8%	1.2	$0.27
11/15/2023	159,700 shares	$57,476.03	+26.1%	2.3%	1.2	$0.36
10/31/2023	126,700 shares	$54,481.00	+21.2%	2.3%	0.9	$0.43
10/15/2023	104,500 shares	$58,509.55	-37.3%	1.9%	0.3	$0.56
9/30/2023	166,700 shares	$102,103.75	+64.7%	3.0%	0.5	$0.61
9/15/2023	101,200 shares	$83,712.64	-30.1%	1.8%	0.3	$0.83
8/31/2023	144,800 shares	$96,581.60	-77.1%	2.6%	0.5	$0.67
8/15/2023	632,100 shares	$453,847.80	+3,108.6%	11.2%	1.9	$0.72
7/31/2023	19,700 shares	$18,518.00	-34.8%	0.4%	0	$0.94
7/15/2023	30,200 shares	$31,408.00	-46.4%	0.6%	0.1	$1.04
6/30/2023	56,300 shares	$65,871.00	-52.3%	1.1%	0.1	$1.17
6/15/2023	118,000 shares	$136,880.00	-27.4%	2.4%	0.1	$1.16
5/31/2023	162,500 shares	$185,250.00	+70.3%	3.4%	0.2	$1.14
5/15/2023	95,400 shares	$98,262.00	-13.2%	2.0%	0.1	$1.03
4/30/2023	109,900 shares	$126,385.00	-51.7%	2.4%	0.2	$1.15
4/15/2023	227,500 shares	$282,100.00	+106.6%	7.2%	0.2	$1.24
3/31/2023	110,100 shares	$198,180.00	+56.0%	3.5%	0.1	$1.80
3/15/2023	70,600 shares	$146,142.00	-59.2%	4.6%	0	$2.07
2/28/2023	173,000 shares	$496,510.00	-7.2%	11.2%	0	$2.87
2/15/2023	186,400 shares	$561,064.00	-52.7%	11.2%	0	$3.01
The real reason Elon is fully endorsing Trump (Ad) Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows,
1/31/2023	393,900 shares	$1.31 million	-26.6%	23.6%	0.1	$3.33
1/15/2023	536,900 shares	$1.99 million	+3.0%	32.2%	0.1	$3.71
12/30/2022	521,100 shares	$1.77 million	+1,060.6%	31.2%	0.1	$3.39
12/15/2022	44,900 shares	$243,986.60	-94.9%	2.8%	0.1	$5.43
11/30/2022	874,900 shares	$367,458.00	-0.2%	N/A	4.4	$0.42
11/15/2022	876,800 shares	$380,881.92	-3.4%	N/A	4.6	$0.43
10/31/2022	907,300 shares	$424,797.86	-11.1%	N/A	4.2	$0.47
10/15/2022	1,020,000 shares	$520,404.00	+1.0%	N/A	4.9	$0.51
9/30/2022	1,010,000 shares	$671,650.00	+2.0%	N/A	4.7	$0.67
9/15/2022	990,000 shares	$801,999.00	-2.0%	N/A	5.6	$0.81
8/31/2022	1,010,000 shares	$859,914.00	+9.8%	N/A	4.7	$0.85
8/15/2022	919,500 shares	$1.05 million	-1.7%	N/A	3.4	$1.14
7/31/2022	935,700 shares	$1.02 million	+3.9%	N/A	3.3	$1.09
7/15/2022	900,500 shares	$1.03 million	-8.0%	N/A	2	$1.14
6/30/2022	978,400 shares	$829,683.20	-13.4%	N/A	2.1	$0.85
6/15/2022	1,130,000 shares	$998,920.00	-18.7%	N/A	2.3	$0.88
5/31/2022	1,390,000 shares	$2.25 million	-0.7%	N/A	3.2	$1.62
5/15/2022	1,400,000 shares	$1.76 million	+5.3%	N/A	3.6	$1.26
4/30/2022	1,330,000 shares	$2.82 million	-1.5%	N/A	3.4	$2.12
4/15/2022	1,350,000 shares	$2.65 million	-6.3%	N/A	4.7	$1.96
3/31/2022	1,440,000 shares	$3.73 million	-4.0%	N/A	4.6	$2.59
3/15/2022	1,500,000 shares	$3.87 million	+5.6%	N/A	4.2	$2.58
2/28/2022	1,420,000 shares	$4.53 million	-6.6%	N/A	2.9	$3.19
2/15/2022	1,520,000 shares	$4.97 million	+13.4%	N/A	1.8	$3.27
1/31/2022	1,340,000 shares	$3.83 million	-8.8%	N/A	1.4	$2.86
1/15/2022	1,470,000 shares	$4.47 million	-7.0%	N/A	1.5	$3.04
12/31/2021	1,580,000 shares	$6.16 million	-18.1%	N/A	1.6	$3.90
12/15/2021	1,930,000 shares	$7.86 million	+37.9%	N/A	2	$4.07
11/30/2021	1,400,000 shares	$8.93 million	+2.2%	N/A	1.3	$6.38
11/15/2021	1,370,000 shares	$5.86 million	-16.0%	N/A	1.8	$4.28
10/29/2021	1,630,000 shares	$8.26 million	+16.4%	N/A	2.4	$5.07
10/15/2021	1,400,000 shares	$7.85 million	-4.8%	N/A	1.9	$5.61
9/30/2021	1,470,000 shares	$7.95 million	-33.8%	N/A	2.1	$5.41
9/15/2021	2,220,000 shares	$14.65 million	+14.4%	N/A	3.3	$6.60
8/31/2021	1,940,000 shares	$11.43 million	+116.6%	N/A	3.9	$5.89
8/13/2021	895,800 shares	$6.96 million	-60.5%	N/A	2	$7.77
7/30/2021	2,270,000 shares	$17.18 million	+3.2%	20.3%	5.7	$7.57
7/15/2021	2,200,000 shares	$20.17 million	-0.5%	19.7%	5.7	$9.17
6/30/2021	2,210,000 shares	$22.10 million	-1.3%	24.2%	1.7	$10.00
6/15/2021	2,240,000 shares	$22.92 million	+2.8%	24.6%	1	$10.23
5/28/2021	2,180,000 shares	$18.62 million	-15.5%	23.9%	0.9	$8.54
5/14/2021	2,580,000 shares	$17.67 million	-9.8%	28.3%	1	$6.85
4/30/2021	2,860,000 shares	$29.66 million	-5.6%	31.4%	1.1	$10.37
4/15/2021	3,030,000 shares	$31.69 million	+25.7%	33.2%	1	$10.46
3/31/2021	2,410,000 shares	$14.80 million	+6.2%	26.4%	0.8	$6.14
3/15/2021	2,270,000 shares	$14.48 million	+6.1%	83.5%	1.3	$6.38
2/26/2021	2,140,000 shares	$9.44 million	+364.0%	78.7%	1.3	$4.41
2/12/2021	461,200 shares	$2.73 million	+54.6%	17.0%	0.3	$5.91
1/29/2021	298,300 shares	$1.04 million	-1.8%	11.0%	0.2	$3.48
1/15/2021	303,900 shares	$948,168.00	No Change	11.2%	0.3	$3.12
The real reason Elon is fully endorsing Trump (Ad) Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows,

ATNF Short Interest - Frequently Asked Questions

What is 180 Life Sciences' current short interest?: Short interest is the volume of 180 Life Sciences shares that have been sold short but have not yet been covered or closed out. As of September 30th, traders have sold 73,300 shares of ATNF short. 14.10% of 180 Life Sciences' shares are currently sold short. Learn More on 180 Life Sciences' current short interest.
What is a good short interest ratio for 180 Life Sciences?: The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ATNF shares currently have a short interest ratio of 1.0. Learn More on 180 Life Sciences's short interest ratio.
What is a good short interest percentage for 180 Life Sciences?: Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.10% of 180 Life Sciences' floating shares are currently sold short.
Is 180 Life Sciences' short interest increasing or decreasing?: 180 Life Sciences saw a increase in short interest in the month of September. As of September 30th, there was short interest totaling 73,300 shares, an increase of 21.0% from the previous total of 60,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
What is 180 Life Sciences' float size?: 180 Life Sciences currently has issued a total of 942,000 shares. Some of 180 Life Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. 180 Life Sciences currently has a public float of 519,800 shares.

How does 180 Life Sciences' short interest compare to its competitors?: 14.10% of 180 Life Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to 180 Life Sciences: Virios Therapeutics, Inc. (2.44%), Hoth Therapeutics, Inc. (4.58%), Guardion Health Sciences, Inc. (1.76%), Alaunos Therapeutics, Inc. (9.47%), Galera Therapeutics, Inc. (5.49%), Adial Pharmaceuticals, Inc. (1.24%), Lixte Biotechnology Holdings, Inc. (1.38%), Soligenix, Inc. (5.61%), Creative Medical Technology Holdings, Inc. (1.95%), Trevena, Inc. (8.55%),
Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.04 billion), AppLovin Co. ($2.69 billion), Nu Holdings Ltd. ($2.64 billion), Paychex, Inc. ($2.61 billion), Cencora, Inc. ($2.30 billion), Aptiv PLC ($2.09 billion), Moderna, Inc. ($2.09 billion), Tractor Supply ($2.04 billion), Coinbase Global, Inc. ($1.97 billion), and International Paper ($1.95 billion). View all of the most shorted stocks.
What does it mean to sell short 180 Life Sciences stock?: Short selling ATNF is an investing strategy that aims to generate trading profit from 180 Life Sciences as its price is falling. ATNF shares are trading up $0.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against 180 Life Sciences?: A short squeeze for 180 Life Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ATNF, which in turn drives the price of the stock up even further.
How often is 180 Life Sciences' short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATNF, twice per month. The most recent reporting period available is September, 30 2024.